Evidentic GmbH

🧬𝗘𝗿𝗿𝗼𝗿-𝗜𝗻𝗱𝘂𝗰𝗲𝗱 𝗖𝗲𝗹𝗹 𝗗𝗲𝗮𝘁𝗵: 𝗔 𝗡𝗲𝘄 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝘁𝗼 𝗧𝗮𝗿𝗴𝗲𝘁𝗶𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗲𝗹𝗹𝘀 🔬   A recent study published in Science Advances reveals a previously unknown process that triggers cell death in cells with errors during division. This discovery could lead to more effective cancer treatments.   𝐇𝐨𝐰 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐰𝐨𝐫𝐤? 🧬 When cells divide, they create two identical copies of themselves. However, sometimes errors occur. This new research shows that when there are too many centrosomes (the structures that organize cell division), a protein complex called the PIDDosome is activated. This complex sets off two deadly processes:   🏭 Mitochondrial damage: It targets the cell's powerhouses, the mitochondria, leading to cell death. 🛡️ Tumor suppressor activation: It activates the tumor suppressor p53, which also triggers cell death.   𝐖𝐡𝐲 𝐢𝐬 𝐭𝐡𝐢𝐬 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭 𝐟𝐨𝐫 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭? 🎗️ Many cancer cells have errors in their cell division process, including extra centrosomes. By understanding this new mechanism, researchers may be able to develop more effective treatments that target these errors.   𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐢𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬? 💡   🧑⚕️Personalized medicine: Doctors could use this knowledge to identify patients who would benefit most from certain cancer drugs. 💊Enhanced drug effectiveness: By understanding how this mechanism works, scientists could develop drugs that work synergistically with existing therapies.   This discovery represents a significant step forward in our understanding of cancer biology and offers new hope for patients with cancer.   Read the full article here: https://lnkd.in/dgrYNyp9   This research was conducted by a team of scientists from Austria and Italy (Dario Rizzotto | Andreas Villunger). Their findings have the potential to significantly impact the field of oncology.   #cancerresearch #bloodcancer #celldivision #science #innovation #research #cancer #medicine #biology #biotech #discovery

💡 𝗖𝗮𝗻 '𝗲𝘅𝗽𝗶𝗿𝗲𝗱' 𝗱𝗿𝘂𝗴 𝗮𝗹𝗶𝗾𝘂𝗼𝘁𝘀 𝗯𝗲 𝘂𝘀𝗲𝗱 𝗳𝗼𝗿 𝗥&𝗗?   Absolutely!   Did you know that drug expiration dates apply only to therapeutic use in humans?   🔬Once repackaged by Evidentic for research, the molecules remain intact and functional - even after expiration.   Once current batches expire, they are classified as "historical", but their chemical properties and biological activities remain intact. This ensures they continue to exhibit their intended functions and mechanisms of action, making them valuable tools for your scientific investigations. 🧬   𝗪𝗵𝘆 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗮𝘁𝘁𝗲𝗿 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵? ✔️ Get valuable insights using fully functional, licensed molecules. ✔️ Maximize the utility of molecules beyond their therapeutic expiration. ✔️ Leverage high-quality, FDA/EMA-approved APIs for your R&D projects.   Let’s discuss! How could historical batches enhance your research? Share your thoughts below or explore our batch library to find the right molecule for your project. 🌟   #DrugDevelopment #ResearchAndDevelopment #ClinicalGradeMolecules #Biologics #Biosimilars #Innovation #Evidentic #ScientificResearch

🌟 Are you looking for therapeutic molecules? 💊   If so, we have just what you need!   Due to special project requirements, we know sometimes the expiry date for human use is a thing. So, we decided to give you the opportunity to access the "fresh" batches from our Evidentic inventory before they become "historical". 🧬⚡️   To view our current selection of molecules and their corresponding expiration dates, please visit our website (link in the comments) or reach out to our customer support team at 📧 info@evidentic.com! 🕒 Quantities are limited, so act fast to secure the fresh molecules you need!   #InnovationInMedicine #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery #Pharmaceuticals #Biotech #TherapeuticMolecules #Laboratory #BiotechSolutions #MoleculeSupply #RAndD

𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆: 𝗔 𝗡𝗲𝘄 𝗘𝗿𝗮 𝗶𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 🚀   As you may have heard, scientists use artificial intelligence (AI) to revolutionize drug discovery. By training a chemical language model, it is now possible to predict molecules with unprecedented accuracy, leading to the development of more effective and targeted therapies. 💊   𝗞𝗲𝘆 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗔𝗜-𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗱𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺:   ⚡Increased speed and efficiency: The AI models can generate and screen millions of potential drug candidates in a fraction of the time it would take traditional methods. 🎯Improved accuracy: The AI models are trained on vast datasets of chemical and biological information, enabling them to make highly accurate predictions. 💡Enhanced creativity: The AI models can generate novel and unexpected solutions, leading to the discovery of groundbreaking new drugs.   Learn more about this topic: https://lnkd.in/dX76fvQF   #AI #drugdiscovery #biotech #innovation #healthcare

🔬 𝗦𝗰𝗮𝗹𝗶𝗻𝗴 𝗗𝗼𝘄𝗻 𝘁𝗼 𝗦𝗰𝗮𝗹𝗲 𝗨𝗽: 𝗙𝗮𝗿𝗶𝗰𝗶𝗺𝗮𝗯 𝗶𝗻 𝗦𝗺𝗮𝗹𝗹 𝗨𝗻𝗶𝘁𝘀 💡   Get a fresh batch of clinical-grade Faricima from the original Vabysmo® commercial drug at Evidentic. Visit our online shop 🛒 and explore our batch library 📚 with other top-quality clinical-grade molecules from original therapeutics. Evidentic offers global access 🌍, reliable sourcing 🔗, and research benefits 📈. Don't miss the opportunity to advance your research! 🧬 #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery #Pharmaceuticals #Biotech #TherapeuticMolecules #MoleculeSupply #RAndD

🧠 𝗖𝗮𝗻 𝗮 𝗦𝗺𝗮𝗿𝘁𝗽𝗵𝗼𝗻𝗲 𝗚𝗮𝗺𝗲 𝗦𝗽𝗼𝘁 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮? 📱   Yes, a simple smartphone game could be the key to early dementia detection!   Researchers have discovered that a "treasure hunt" app can identify individuals at risk of dementia based on their navigation behavior. By tracking participants as they searched for specific locations on a university campus, scientists were able to spot subtle differences in movement patterns, especially in those showing early cognitive decline.🗺️   𝗞𝗲𝘆 𝗙𝗶𝗻𝗱𝗶𝗻𝗴𝘀 📉 Early detection: The app identified people with subjective cognitive decline (SCD) — a known dementia risk factor — based on their navigation. 🌍 Real-world setting: Using a natural task made it a more realistic assessment of cognitive function. 🏥 Potential for intervention: Early detection means timely interventions that could slow down the disease.   💡 𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻 𝗳𝗼𝗿 𝗱𝗲𝗺𝗲𝗻𝘁𝗶𝗮 𝗰𝗮𝗿𝗲? Imagine diagnosing dementia years before symptoms become severe. With smartphone apps and AI, we could revolutionize early detection and treatment!   Would you try it - and even more important - trust the results? 🤔   Read the full article here: https://lnkd.in/dbXUwyJW   #Dementia #Alzheimers #EarlyDetection #SmartphoneApp #CognitiveDecline #BrainHealth #DigitalHealth #Neuroscience #AI #MachineLearning #HealthcareInnovation #HealthTech

📢 𝗪𝗲'𝗿𝗲 𝗛𝗶𝗿𝗶𝗻𝗴 𝗮 𝗧𝗲𝗮𝗺 𝗔𝘀𝘀𝗶𝘀𝘁𝗮𝗻𝘁! 📢   Are you an organized, team-oriented professional with experience as a Team Assistant or in office management? 🗂️✨   We're looking for a Team Assistant to join our amazing team!   Expect a welcoming work environment, diverse responsibilities, and the chance to enhance your skills every day. 🌟   Ready to make an impact? Apply now! 👉 info@evidentic.com   #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery #Hiring #TeamAssistant

💊 𝐋𝐨𝐰 𝐢𝐧 𝐒𝐭𝐨𝐜𝐤 𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬! 🛒   🧪 In early drug development, researchers deal with some challenges. Don't let the access to licensed molecules be one of them.   If you're in need of small units from licensed drugs, we've got you covered. Take a look at our current selection of rare drug aliquots and see if any of our unique batches align with your research project. Additionally, we introduce the historical batches of the rare molecules that are almost out of stock and cannot be replaced. 📦💊   We encourage you to act quickly before they sell out completely. Check our online shop link in the comments! 🛒🔬   #InnovationInMedicine #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery

🎁 𝐃𝐨𝐧'𝐭 𝐌𝐢𝐬𝐬 𝐭𝐡𝐞 𝐒𝐡𝐢𝐩𝐩𝐢𝐧𝐠 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞 𝐟𝐨𝐫 𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬! 🌟   The Christmas holidays are ahead, as well as our shipping deadlines. Do you have all molecules you need in clinical-grade quality for 2024? 🧪 If not, check our website to explore our in-stock material. (Link in the comments.)    🚚🎄To ensure a smooth shipping and delivery of your drug aliquots before the holidays, please take note of our end-of-year shipping deadlines for 2024:   🌎 Worldwide: December 6th, 2024 🇪🇺 EU/Europe: December 13th, 2024   To process and prepare your shipment before Christmas, please send your order confirmation/purchase order one week before the mentioned dates to Evidentic. 📦🎄   Find the right molecule for your research and early drug development program on our website. To meet your research and development needs, we are constantly expanding our stock with new products and licensed molecules in our batch library, such as Amivantamab (Rybrevant®), Pembrolizumab (Keyruda®), Faricimab (Vabysmo®), and many more. 📊 #Evidentic #ChristmasShipping #MoleculeDelivery #YearEndDeadlines #BioTech #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #BetterHealth 🚚📆🎉📚🌐

🧬 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗶𝗻 𝗖𝗲𝗹𝗹 𝗕𝗶𝗼𝗹𝗼𝗴𝘆: 𝗡𝗲𝘄 𝗛𝗼𝗽𝗲 𝗳𝗼𝗿 𝗟𝗥𝗕𝗔 𝗗𝗲𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 🧫   Researchers at the Universität Basel have uncovered a crucial mechanism in the rare, immune-related disease LRBA deficiency!   Their study, published in the Journal of Cell Biology, reveals that two key recycling steps in cells are disrupted in patients, not just one.   𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻? ⚠️ Enlarged endolysosomes: The cellular "waste plants" are overloaded in LRBA deficiency, impairing vital cell functions. 🚨 Increased secretion: Cells release too many organelles, causing inflammation and tissue damage.   𝗪𝗵𝘆 𝗶𝘀 𝘁𝗵𝗶𝘀 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁? Until now, therapies only targeted the first defective pathway. This new discovery paves the way for treatments addressing the second, previously overlooked defect! 🌟   Read the full article here: https://lnkd.in/dTjM5_i2   #LRBAdeficiency #AutoimmuneDisease #CellBiology #MedicalResearch #Pharma #Biotechnology #Science #ImmuneSystem #GeneticResearch #MedicalInnovation